Cytomegalovirus colitis in immunocompetent critically ill patients

International Journal of Infectious Diseases

Volumn 20, Issue 1, 2014, Pages 71-73

  Siciliano, Rinaldo F ^a   Castelli, Jussara B ^a   Randi, Bruno A ^a   Vieira, Ricardo D ^a   Strabelli, Tânia M V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Colitis; Critically ill; Cytomegalovirus; Intensive care

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; EOSIN; GANCICLOVIR; HEMATOXYLIN; VASOACTIVE AGENT; ANTIBODY; VIRUS ANTIGEN;

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CLINICAL FEATURE; COLITIS; CRITICALLY ILL PATIENT; CYTOMEGALOVIRUS END ORGAN DISEASE; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; INTENSIVE CARE UNIT; MALE; MEDICAL RECORD; MIDDLE AGED; RETROSPECTIVE STUDY; SEPTIC SHOCK; STROMA CELL; TEACHING HOSPITAL; VERY ELDERLY; ARTIFICIAL VENTILATION; COMORBIDITY; CYTOMEGALOVIRUS; INTENSIVE CARE; INTENSIVIST; MEDICAL RECORD REVIEW; MORTALITY; SHOCK; STAINING;

COLITIS; CRITICALLY ILL; CYTOMEGALOVIRUS; INTENSIVE CARE;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; COMORBIDITY; CRITICAL ILLNESS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; HOSPITAL MORTALITY; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; INTENSIVE CARE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84895151068     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.11.008     Document Type: Article

References (10)

1. Kalil A.C., Florescu D.F. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med 2009, 37:2350-2358.
2. Osawa R., Singh N. Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care 2009, 13:R68.
3. Galiatsatos P., Shrier I., Lamoureux E., Szilagy A. Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig Dis Sci 2005, 50:609-616.
4. Cook C.H., Trgovivh J. Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges. Antivir Res 2011, 90:151-159.
5. Klauber E., Briski L.E., Khatib R. Cytomegalovirus colitis in the immunocompetent host: an overview. Scand J Infect Dis 1998, 30:559-564.
6. Rafailidis P.I., Mourtzoukou E.G., Varbobitis I.C., Falagas M.E. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 2008, 5:47.
7. Heininger A., Jahn G., Engel C., Notheisen T., Unertl K., Hamprecht K. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care 2001, 29:541-547.
8. Jain M., Duggal S., Chug T.D. Cytomegalovirus infection in non-immunosuppressed critically ill patients. J Infect Dev Ctries 2011, 5:571-579.
9. Patel S.M., Cohen P., Pickering M.C., Gazzard B.G., Adreyev J. Successful treatment of acute haemorrhagic cytomegalovirus colitis with ganciclovir in and individual without overt immunocompromise. Eur J Gastroenterol Hepatol 2003, 15:1055-1060.
10. Wohl D.A., Kendall M.A., Andersen J., Crumpacker C., Spector S.A. Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030. HIV Clin Trials 2009, 10:143-152.